Cargando…
Prognostic risk model development and prospective validation among patients with cervical cancer stage IB2 to IIB submitted to neoadjuvant chemotherapy
This study was designed to develop a risk model for disease recurrence among cervical cancer patients who underwent neoadjuvant chemotherapy and radical surgery. Data for 853 patients were obtained from a retrospective study and used to train the model, and then data for 447 patients from a prospect...
Autores principales: | Huang, Kecheng, Sun, Haiying, Li, Xiong, Hu, Ting, Yang, Ru, Wang, ShaoShuai, Jia, Yao, Chen, Zhilan, Tang, Fangxu, Shen, Jian, Qin, Xiaomin, Zhou, Hang, Yang, Runfeng, Gui, Juan, Wang, Lin, Zhao, Xiaolin, Zhang, Jincheng, Liu, Jiong, Guo, Lili, Li, Shuang, Wang, Shixuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899714/ https://www.ncbi.nlm.nih.gov/pubmed/27279023 http://dx.doi.org/10.1038/srep27568 |
Ejemplares similares
-
Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy
por: Huang, Kecheng, et al.
Publicado: (2016) -
Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery
por: Sun, Haiying, et al.
Publicado: (2018) -
Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
por: Chen, Zhilan, et al.
Publicado: (2016) -
The Predictive Value of Serum Squamous Cell Carcinoma Antigen in Patients with Cervical Cancer Who Receive Neoadjuvant Chemotherapy followed by Radical Surgery: A Single-Institute Study
por: Li, Xiong, et al.
Publicado: (2015) -
Early response to neoadjuvant chemotherapy can help predict long-term survival in patients with cervical cancer
por: Li, Xiong, et al.
Publicado: (2016)